Pierre Olivier Lang

4.5k total citations
128 papers, 3.2k citations indexed

About

Pierre Olivier Lang is a scholar working on Geriatrics and Gerontology, Epidemiology and Physiology. According to data from OpenAlex, Pierre Olivier Lang has authored 128 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Geriatrics and Gerontology, 28 papers in Epidemiology and 28 papers in Physiology. Recurrent topics in Pierre Olivier Lang's work include Pharmaceutical Practices and Patient Outcomes (27 papers), Health Systems, Economic Evaluations, Quality of Life (20 papers) and Nutrition and Health in Aging (19 papers). Pierre Olivier Lang is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (27 papers), Health Systems, Economic Evaluations, Quality of Life (20 papers) and Nutrition and Health in Aging (19 papers). Pierre Olivier Lang collaborates with scholars based in Switzerland, United Kingdom and France. Pierre Olivier Lang's co-authors include Jean‐Pierre Michel, Richard Aspinall, Dina Zekry, Thomas Vogel, Jean‐Pierre Baeyens, E. Schmitt, Eva Topinková, Walid Bouaziz, Georges Kaltenbach and Bernard Gény and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American Geriatrics Society and Frontiers in Immunology.

In The Last Decade

Pierre Olivier Lang

122 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Olivier Lang Switzerland 29 1.3k 759 625 513 438 128 3.2k
Virginia Towle United States 26 900 0.7× 223 0.3× 572 0.9× 839 1.6× 701 1.6× 38 3.7k
Kathryn Richardson United Kingdom 32 769 0.6× 681 0.9× 283 0.5× 710 1.4× 191 0.4× 76 4.0k
Marianna Noale Italy 38 556 0.4× 785 1.0× 269 0.4× 513 1.0× 452 1.0× 158 3.9k
Beata Jankowska‐Polańska Poland 31 562 0.4× 456 0.6× 357 0.6× 243 0.5× 428 1.0× 181 2.7k
Onchee Yu United States 32 385 0.3× 195 0.3× 355 0.6× 1.6k 3.2× 408 0.9× 93 5.0k
Qiukui Hao China 33 1.1k 0.9× 1.8k 2.4× 286 0.5× 542 1.1× 244 0.6× 133 4.2k
Francesca Cunningham United States 28 520 0.4× 154 0.2× 397 0.6× 337 0.7× 273 0.6× 109 2.9k
Stephen DeWilde United Kingdom 31 228 0.2× 409 0.5× 322 0.5× 646 1.3× 615 1.4× 71 3.1k
Mateu Serra‐Prat Spain 33 580 0.4× 1.4k 1.8× 273 0.4× 718 1.4× 295 0.7× 141 5.1k
Angelo Carfì Italy 19 368 0.3× 225 0.3× 219 0.4× 364 0.7× 238 0.5× 41 4.5k

Countries citing papers authored by Pierre Olivier Lang

Since Specialization
Citations

This map shows the geographic impact of Pierre Olivier Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Olivier Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Olivier Lang more than expected).

Fields of papers citing papers by Pierre Olivier Lang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Olivier Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Olivier Lang. The network helps show where Pierre Olivier Lang may publish in the future.

Co-authorship network of co-authors of Pierre Olivier Lang

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Olivier Lang. A scholar is included among the top collaborators of Pierre Olivier Lang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Olivier Lang. Pierre Olivier Lang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lutters, Monika, Patrick E. Beeler, Pierre Olivier Lang, et al.. (2022). Automatic Detection of Adverse Drug Events in Geriatric Care: Study Proposal. JMIR Research Protocols. 11(11). e40456–e40456. 3 indexed citations
2.
Hirt, Julian, et al.. (2020). Instruments assessing medication literacy in adult recipients of care: A systematic review of measurement properties. International Journal of Nursing Studies. 113. 103785–103785. 27 indexed citations
3.
Lang, Pierre Olivier, Pierre Loulergue, & Richard Aspinall. (2017). Chikungunya Virus Infection: Why Should U.S. Geriatricians Be Aware of It?. Journal of the American Geriatrics Society. 65(11). 2529–2534. 8 indexed citations
4.
Lang, Pierre Olivier, et al.. (2017). Comment j’optimise un traitement complexe chez un patient âgé. IRIS. 23(3). 145–157. 1 indexed citations
5.
6.
Reich, Johannes, Pierre Olivier Lang, Holger Grallert, & H. Motschmann. (2016). Masking of endotoxin in surfactant samples: Effects on Limulus-based detection systems. Biologicals. 44(5). 417–422. 49 indexed citations
7.
Rousseau, Amélie, et al.. (2016). Prescriptions et administrations inappropriées de médicaments dans dix établissements alsaciens d’hébergement pour personnes âgées dépendantes – France. Revue d Épidémiologie et de Santé Publique. 64(2). 95–101. 10 indexed citations
8.
Lang, Pierre Olivier, Benoît Boland, & Olivia Dalleur. (2015). Prescription médicamenteuse inappropriée : les nouveaux critères STOPP/START. Revue Médicale Suisse. 494. 2115–2123. 1 indexed citations
9.
Samaras, Dimitrios, et al.. (2012). Statut en [b]vitamines[/b] et en oligo-éléments : impact des médicaments. Revue Médicale Suisse. 8(344). 1229–1236. 1 indexed citations
10.
Samaras, Nikolaos, Dimitrios Samaras, Claude Pichard, et al.. (2012). [b]Bronchopneumopathie[/b] chronique obstructive : risques et bénéfices d’un traitement de testostérone. Revue Médicale Suisse. 8(363). 2224–2227. 1 indexed citations
11.
Topinková, Eva, Jean‐Pierre Baeyens, Jean‐Pierre Michel, & Pierre Olivier Lang. (2012). Evidence-Based Strategies for the Optimization of Pharmacotherapy in Older People. Drugs & Aging. 29(6). 477–494. 111 indexed citations
12.
Dramé, Moustapha, Jean‐Luc Novella, Damien Jolly, et al.. (2011). Rapid cognitive decline, one-year institutional admission and one-year mortality: Analysis of the ability to predict and inter-tool agreement of four validated clinical frailty indexes in the safes cohort. The journal of nutrition health & aging. 15(8). 699–705. 21 indexed citations
13.
14.
Samaras, Dimitrios, Nikolaos Samaras, Pauline Coti Bertrand, et al.. (2011). Comparison of the Interobserver Variability of 2 Different Methods of Dietary Assessment in a Geriatric Ward: A Pilot Study. Journal of the American Medical Directors Association. 13(3). 309.e9–309.e13. 2 indexed citations
15.
Lang, Pierre Olivier, Moustapha Dramé, Rachid Mahmoudi, et al.. (2011). Frailty: learnings from the SAFEs cohort study and future perspectives for the research. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. 9(2). 135–149. 4 indexed citations
16.
Baeyens, Jean‐Pierre, Pierre Olivier Lang, & Jean‐Pierre Michel. (2009). Willingness to vaccinate and to be vaccinated in adults. Aging Clinical and Experimental Research. 21(3). 244–249. 22 indexed citations
17.
Lang, Pierre Olivier, et al.. (2009). Stop shingles in its tracks.. PubMed. 58(10). 531–4. 8 indexed citations
18.
Lang, Pierre Olivier, Jean‐Pierre Michel, & Dina Zekry. (2009). Frailty Syndrome: A Transitional State in a Dynamic Process. Gerontology. 55(5). 539–549. 472 indexed citations
19.
Kiesmann, Michèle, et al.. (2004). Evaluation par l'inventaire Neuropsychiatrique (NPI) des symptômes comportementaux et psychologiques aux différents stades de la maladie d'Alzheimer. 29(8). 605–612. 1 indexed citations
20.
Lang, Pierre Olivier, et al.. (2001). Excretion of low molecular weight heparin in human milk. British Journal of Clinical Pharmacology. 52(6). 708–710. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026